Skip to content
akaturk Academic measurement

Academician profile · DOKTOR ÖĞRETİM ÜYESİ (Unvan:Doçent)

YALDA HEKMATSHOAR

ALTINBAŞ ÜNİVERSİTESİ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Tıbbi Biyoloji
  • TIP FAKÜLTESİ
  • TEMEL TIP BİLİMLERİ BÖLÜMÜ
Articles YÖKSİS 32 OpenAlex 6
Projects 1
Books 4
Proceedings 27
Patents 1
Artistic 1
Scopus (SJR)
Q1 6 Q2 11 Q3 6 Q4 1
WoS (JCR)
Q1 3 Q2 5 Q3 8 Q4 7
TR Index 4 articles

Scopus (SJR)

WoS (JCR)

TR Index

4 articles

YÖKSİS: 32 · OpenAlex: 6

Articles

  1. 2025 Combating chronic kidney disease-associated cachexia: A literature review of recent therapeutic approaches BMC Nephrology DOI 10.1186/s12882-025-04057-8
  2. 2025 Multifaceted Therapeutic Potential of Plant-Derived Exosomes: Immunomodulation, Anticancer, Anti-Aging, Anti-Melanogenesis, Detoxification, and Drug Delivery Biomolecules DOI 10.3390/biom15030394
  3. 2025 Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia Cells Biomolecules DOI 10.3390/biom15091245
  4. 2025 Identification of Mitochondrial-Related Genes as Potential Biomarkers for Docetaxel-Resistant Prostate Cancer Journal of Ankara University Faculty of Medicine DOI 10.4274/atfm.galenos.2025.82957
  5. 2025 KÜÇÜK HÜCRELİ VE KÜÇÜK HÜCRELİ OLMAYAN AKCİĞER KANSERLERİNDE ROL OYNAYAN MIRNA’LARIN BİYOİNFORMATİK ANALİZLERLE KARŞILAŞTIRILMASI Ankara Universitesi Eczacilik Fakultesi Dergisi DOI 10.33483/jfpau.1529091
  6. 2024 Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemia Naunyn Schmiedebergs Arch Pharmacol DOI 10.1007/s00210-024-03198-1
  7. 2024 Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study Nucleosides, Nucleotides & Nucleic Acids DOI 10.1080/15257770.2023.2296021
  8. 2024 Methylsulfonylmethane induces caspase-dependent apoptosis in acute myeloid leukemia cell lines Fundam Clin Pharmacol DOI 10.1111/fcp.13030
  9. 2024 Nilotinib exhibits less toxicity than imatinib and influences the immune state by modulating iNOS, p-p38 and p-JNK in LPS/IFN gamma-activated macrophages Toxicology in Vitro DOI 10.1016/j.tiv.2023.105754
  10. 2024 Global DNA Methylation analysis of imatinib resistant and sensitive K562 cells Ege Tıp Bilimleri Dergisi DOI 10.33713/egetbd.1450605
  11. 2024 The Impact of Olaparib on Metabolic Pathways in Triple Negative Breast Cancer: A Bioinformatics Approach Medical Records DOI 10.37990/medr.1529503
  12. 2023 Phenotypic and functional characterization of subpopulation of Imatinib resistant chronic myeloid leukemia cell line Advances in Medical Sciences DOI 10.1016/j.advms.2023.06.002
  13. 2023 Some 2-[4-(1 H -benzimidazol-1-yl) phenyl]-1 H -benzimidazole derivatives overcome Imatinib resistance by induction of apoptosis and reduction of P-glycoprotein activity Chemical Biology & Drug Design DOI 10.1111/cbdd.14343
  14. 2023 DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Mediterranean Journal of Hematology and Infectious Diseases DOI 10.4084/MJHID.2023.008
  15. 2023 Entegre miRNA/mRNA Düzenleyici Ağ Analizi ile Glioblastomada Temozolomid Direnç Faktörlerinin Belirlenmesi Ege Tıp Bilimleri Dergisi DOI 10.33713/egetbd.1400022
  16. 2022 Evidence for Health-Promoting Properties of Lepidium sativum L.: An Updated Comprehensive Review Turkish Journal of Pharmaceutical Sciences DOI 10.4274/tjps.galenos.2021.07504
  17. 2022 AN INVESTIGATION ON THE EFFECTS OF SIRT5 MODULATORS ON SIRT5 AND CYTOCHROME C PROTEIN EXPRESSIONS IN K562 CHRONIC MYELOID LEUKEMIA CELL LINE Ankara Universitesi Eczacilik Fakultesi Dergisi DOI 10.33483/jfpau.1081893
  18. 2021 Cytotoxic effect of 6-Shogaol in Imatinib sensitive and resistant K562 cells Molecular Biology Reports DOI 10.1007/s11033-021-06141-2
  19. 2021 Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells Leukemia Research DOI 10.1016/j.leukres.2021.106523
  20. 2020 β-catenin mutations in acute myeloid leukemia Egyptian Journal of Haematology DOI 10.4103/ejh.ejh_54_19

Back to academicians